Loder, E. W., & Robbins, M. S. (2018). Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea. JAMA: Journal of the American Medical Association, 319(19), 1985. https://doi.org/10.1001/jama.2018.4852
Chicago Style (17th ed.) CitationLoder, Elizabeth W., and Matthew S. Robbins. "Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea." JAMA: Journal of the American Medical Association 319, no. 19 (2018): 1985. https://doi.org/10.1001/jama.2018.4852.
MLA (9th ed.) CitationLoder, Elizabeth W., and Matthew S. Robbins. "Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea." JAMA: Journal of the American Medical Association, vol. 319, no. 19, 2018, p. 1985, https://doi.org/10.1001/jama.2018.4852.